| Number of Patients, Male | 28 |
| Number of Patients, Female | 4 |
| Stage | Histologically confirmed stage III/IV SCC/adenocarcinoma of the esophagus or SCC/adenocarcinoma of the gastroesophageal junction accompanied by high expression of VEGFR2 |
| Age | Median (range): 60 (23–72) years |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.